*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Life Science REIT plc is a newly incorporated, externally managed, investment company that intends to carry on business as a REIT and, upon admission, will be an "investing company" for the purposes of the AIM Rules. The Company's investment objective is to provide shareholders with an attractive level of total return. The focus will be capital growth whilst also providing a growing level of income by investing primarily in a diversified portfolio of UK properties that are leased or intended to be leased to tenants operating in the life science sector. The investment strategy targets life science clusters that are focused primarily in the "Golden Triangle" of Oxford, Cambridge and London and also selective opportunities in other emerging clusters around the UK.
Claire Boyle (née Barnes)
Senior Independent Director:
Independent Non-Executive Director:
Michael Taylor, Sally Ann Forsyth
Beaufort House, 51 New North Road, Exeter, United Kingdom